NCT06984679 Physical Impairments in Children With Cystic Fibrosis
| NCT ID | NCT06984679 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Izmir Democracy University |
| Condition | Cystic Fibrosis (CF) |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-09-15 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-09-15 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is aimed to reveal impairments regarding urinary incontinence, dyspnea, muscle strength, functional capacity or quality of life in children and adolescents with cystic fibrosis compared to healthy children and adolescents.
Eligibility Criteria
Inclusion Criteria for Children and Adolescents with Cystic Fibrosis: * To be between the ages of 6-18 * To have been diagnosed with cystic fibrosis * To be clinically stable for at least 3 weeks * To have the necessary cooperation for the measurements * To volunteer to participate in the study Inclusion Criteria for Healthy Children and Adolescents: * To be between the ages of 6-18 * To be in a similar average and ratio with the group of children and adolescents with cystic fibrosis in terms of age and gender * To have the necessary cooperation for the measurements * To volunteer to participate in the study Exclusion Criteria for Children and Adolescents with Cystic Fibrosis: * Having any orthopedic, neurological, psychological or cardiovascular problem that may prevent the measurements from being performed in the last 6 months * Smoking or quitting smoking Exclusion Criteria for Healthy Children and Adolescents: * Having any orthopedic, neurological, psychological or cardiovascular problem that may prevent the measurements from being performed in the last 6 months * Having any chronic disease * Smoking or quitting smoking
Contact & Investigator
Gülşah Barğı, Assoc Prof
STUDY DIRECTOR
Izmir Democracy University
Frequently Asked Questions
Who can join the NCT06984679 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Cystic Fibrosis (CF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06984679 currently recruiting?
Yes, NCT06984679 is actively recruiting participants. Contact the research team at gulsahbargi35@gmail.com for enrollment information.
Where is the NCT06984679 trial being conducted?
This trial is being conducted at Izmir, Turkey (Türkiye).
Who is sponsoring the NCT06984679 clinical trial?
NCT06984679 is sponsored by Izmir Democracy University. The principal investigator is Gülşah Barğı, Assoc Prof at Izmir Democracy University. The trial plans to enroll 50 participants.